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The recent emergence and spread of dengue hemorrhagic fever in the Americas have been a major source of concern.
Efforts to control this disease are dependent on understanding the pathogenicity of dengue viruses and their transmission
dynamics. Pathogenicity studies have been hampered by the lack of in vitro or in vivo models of severe dengue disease.
Alternatively, molecular epidemiologic studies which associate certain dengue virus genetic types with severe dengue
outbreaks may point to strains with increased pathogenicity. The comparison of nucleotide sequences (240 bp) from the
E/NS1 gene region of the dengue virus genome has been shown to reflect evolutionary relationships and geographic origins
of dengue virus strains. This approach was used to demonstrate an association between the introduction of two distinct
genotypes of dengue type 2 virus and the appearance of dengue hemorrhagic fever in the Americas. Phylogenetic analyses
suggest that these genotypes originated in Southeast Asia and that they displaced the native, American genotype in at
least four countries. Vaccination and other control efforts should therefore be directed at decreasing the transmission of
these ‘‘virulent’’ genotypes. q 1997 Academic Press
INTRODUCTION described; immunity to one serotype does not protect
against infection by the others. In fact, sequential infec-
The importance of dengue virus as a disease-causing
tion by another serotype substantially increases the
agent has been discussed in many recent publications
probability of developing DHF; immune-enhancement of
(Centers for Disease Control, 1994a,b; Gubler and Clark,
infection was first suggested (Halstead, 1970) and later
1995; Institute of Medicine, 1992; Monath, 1994; National
demonstrated in infants who passively acquired dengue
Institute of Allergy and Infectious Diseases, 1992); it is
antibodies in utero (Kliks et al., 1989). Prospective clinical
responsible for growing health problems in tropical and
studies have suggested that release of cytokines, inter-
subtropical regions of the world. This mosquito-borne
feron, and complement pathway components amplifies
flavivirus causes illness varying from a mild, flu-like syn-
the pathological process begun by these nonneutralizingdrome (dengue fever, DF) to a fulminating hemorrhagic
antibodies (Kurane et al., 1994). However, the pathogene-disease with hypovolemic shock and death (dengue
sis of DHF is poorly understood mainly due to the lackhemorrhagic fever, DHF). At present, as many as 50 mil-
of both in vitro and in vivo models of disease.lion human cases occur annually, with an estimated
The first indications of differences in virulence and/or10,000 infant deaths due to the hemorrhagic form of den-
transmission between dengue viruses came from de-gue (World Health Organization, 1996).
scriptions of sylvatic cycles of virus transmission in for-The severe form of dengue is thought to be caused
ests in Western Africa (Robin et al., 1980), Vietnam (Worldby several factors, including virus type and host immune
Health Organization, 1976), and Malaysia (Rudnick,status. Four closely related but antigenically distinct den-
1965). Only recently have some of these serotype 2 vi-gue virus serotypes (designated types 1–4) have been
ruses been analyzed genetically, and their distinct evolu-
tionary origins were proven (Rico-Hesse, 1990). These
viruses are transmitted by discrete vectors (canopy-in-The nucleotide sequence data reported in this paper have been
submitted to the GenBank nucleotide sequence database and have habiting mosquitoes), among primates, and have not yet
been assigned the Accession Nos. U91859–U91891.
been implicated as causes of outbreaks in nearby human1 To whom reprint requests should be addressed at present address:
populations (Roche et al., 1983). Other indications of viru-Department of Virology and Immunology, Southwest Foundation for
Biomedical Research, P.O. Box 760549, San Antonio, TX 78245. lence differences among dengue type 2 viruses come
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from recent outbreaks of DHF in the Caribbean and South used to infect C6/36 mosquito cells and viruses were
America. Although several serotypes of dengue had been identified as dengue serotype 2 by indirect fluorescent
circulating in Cuba and the rest of the Americas, it was antibody tests with type-specific monoclonal antibodies
not until 1981 that an epidemic with severe disease oc- (Gubler et al., 1984). Virus isolation and passage histories
curred in Cuba (Gubler and Clark, 1995). During this epi- are given in Table 1; viruses described here were iso-
demic associated with dengue type 2 virus, a total of lated or amplified from human serum, except strain
almost 350,000 cases of dengue were reported, which PM33974, which was isolated from a mosquito pool.
included over 10,000 cases of DHF and 158 deaths (Kouri
RNA extraction and RT-PCRet al., 1986). A recent report by Cuban researchers (Guz-
man et al., 1995) described a genetic study of four den- Nucleotide sequences for 18 of the 62 dengue type 2
gue type 2 isolates from the 1981 epidemic, but provided viruses described here were obtained previously by
insufficient data for direct comparison to phylogenies primer-extension sequencing from viral-extracted RNA
published previously (Blok et al., 1991; Lewis et al., 1993; (Rico-Hesse, 1990); the remainder were amplified by RT-
Rico-Hesse, 1990). Partial nucleotide sequences from the PCR. In a preliminary test comparing nucleotide se-
E (201 bp) gene placed the Cuban viruses in a genetic quences obtained by these two methods (direct RNA
group containing other isolates from Southeast Asia sequencing vs RT-PCR), no differences were seen in the
(Guzman et al., 1995). The virus isolations made during 240-nucleotide-long E/NS1 region used for phylogenies;
this epidemic have not been made available for study, 6 viruses were compared after two to three cell culture
although isolates from neighboring areas have (Jamaica); (C6/36) passages and RNA sequencing to those se-
genetic analyses of these contemporaneous samples re- quences obtained after RT-PCR and no cell passage (i.e.,
vealed their probable origin to be somewhere in South- from serum).
east Asia, presumably Vietnam, Malaysia, or Thailand For 44 of the viruses shown here, a 200-ml aliquot of
(Deubel et al., 1993; Lewis et al., 1993; Rico-Hesse, 1990). cell culture supernatant or human serum was treated
Only since 1981, after the Cuban epidemic, have many with 1.0 ml of Trizol (GIBCO-BRL); RNA extractions were
other countries in the Americas reported DHF cases on done according to the manufacturer’s protocol. The RNA
an annual basis (Gubler and Clark, 1995; World Health was resuspended in DEPC-treated water and 15 of thisOrganization, 1994). The second outbreak of DHF took sample was added to Superscript II RT buffer (50 mM
place in Venezuela, in 1989; isolates of serotypes 1, 2, Tris–HCl, 75 mM KCl, 3 mM MgCl2 , pH 8.3) (GIBCO-
and 4 were obtained during the epidemic, but severe BRL), 10 mM DTT, and 50 pM antisense primer (D2/
cases were associated with type 2 virus (Pan American 2578: 5*-TTACTGAGCGGATTCCACAGATGCC-3* ) which
Health Organization, 1990). Colombia reported its first hybridizes to all known dengue serotype 2 viruses (Rico-
confirmed DHF cases in 1990, presumably as spillover Hesse, 1990). The solution was heated to 907 for 90 sec
from the outbreak in Venezuela (Pan American Health and cooled on ice. Each of the four deoxynucleotides
Organization, 1990, 1992). A third outbreak of DHF began was added (1 mM) along with 40 U Rnasin (Promega)
in Brazil, in 1990, and was also associated with type 2 and 200 U reverse transcriptase enzyme (Superscript II;
virus (Pan American Health Organization, 1992) (No-
GIBCO-BRL). The mixture was incubated for 1 hr at 427
gueira et al., 1993). For Mexico, only sporadic DHF cases
and cooled on ice. To this mix were added both PCR
were reported for the period 1984–1993; however, in
primers (D2/2578 and D2/2170V: 5*-ATGGCCATTTTA-1995, there were 358 confirmed cases of DHF, with a
GGTGACACAGCCTGGGA-3*, sense) (150 pM), PCRvast majority of virus isolates belonging to serotype 2
buffer at pH 10.0 (60 mM Tris–HCl, 15 mM (NH4)2SO4 ,(Briceno-Garcia et al., 1996). By 1995, 14 countries in the
1.5 mM MgCl2), and deoxynucleotides at 0.2 mM, and theAmericas had reported confirmed DHF cases, and DHF
volume brought up to 50 ml with DEPC water. AmpliTaqis endemic in many of these areas (Gubler and Clark,
enzyme (Perkin–Elmer) was added last (5 U) and the1995).
solution overlayed with mineral oil. The samples, includ-In this report we demonstrate the association between
ing positive PCR control (Perkin–Elmer), negative controlthe introduction of a Southeast Asian genotype of dengue
(DEPC water), and dengue type 2 RNA control, weretype 2 virus and the appearance of DHF in four American
placed in a thermal cycler for 30 cycles of 947 for 60 sec,countries (Venezuela, Brazil, Colombia, and Mexico). This
557 for 2 min, and 727 for 3 min. The samples were keptimported dengue genotype seems to have displaced the
at 47 after amplification. The entire sample was electro-native, American genotype which had only been associ-
phoresed in 2% NuSieve GTG agarose (FMC) and stainedated with less severe disease (DF).
with 1 mg/ml ethidium bromide for visualization of bands.
MATERIALS AND METHODS This protocol produced a 408-bp product for sequencing;
Viruses the 240-nucleotide fragment for genetic comparison is
included within this product (Rico-Hesse, 1990). SpecificDengue viruses used in this study were selected from
stocks or serum kept at our laboratories; aliquots were amplification of RNA from virus strains belonging to five
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TABLE 1
Dengue Type 2 Viruses Compared by Sequence Analysis
Strain Passage historya Locationb Year Clinicalc
NGC monk.1,mosq.1,C6/36 1 New Guinea 1944 DF
TR1751 smb. 57 Trinidad 1954 DF
16681 MK2 1, C6/36 5 Bangkok, Thailand 1964 DHF
PR159 PGMK 6 Puerto Rico 1969 DF
D79-014 MK2 2, C6/36 1 Bangkok, Thailand 1979 DF
D80-141 MK2 3, C6/36 1 Bangkok, Thailand 1980 DHF
1318 mosq.2,C6/36 1 Puerto Rico 1981 DF
8110827 None Jamaica 1981 DF
PM33974 mosq.1,C6/36 1 Republic of Guinea 1981 Ae.africanus
D81-081 C6/36 1 Bangkok, Thailand 1981 DHF
D82-137 C6/36 1 Bangkok, Thailand 1982 DF
1329 mosq.1, C6/36 2 Jamaica 1982 DF
JAH C6/36 2 Jamaica 1982 DF
044 C6/36 2 Tapachula, Chiapas, Mexico 1983 DF
D83-516 Ts1, C6/36 2 Bangkok, Thailand 1983 DF
975 C6/36 3 Sri Lanka 1985 DF
348600 C6/36 3 Tumaco, Narin˜o, Colombia 1986 DF
D86-004 Ts 1, C6/36 1 Bangkok, Thailand 1986 DHF
D87-1372 Ts 1, C6/36 1 Bangkok, thailand 1987 DF
24H C6/36 1 Hanoi, Vietnam 1987 DF
57S C6/36 1 Saigon, Vietnam 1987 DF
VEN2 AP61 2 Maracay, Aragua, Venezuela 1987 DF
350447 C6/36 3 Tolima, Colombia 1987 DF
351863 C6/36 3 Tolima, Colombia 1988 DF
D89-1092 Ts 1, C6/36 1 Bangkok, Thailand 1989 DHF
D90-276 Ts 1, C6/36 1 Bangkok, Thailand 1990 DHF
MARA3 None Maracay, Aragua, Venezuela 1990 DF
95524 C6/36 1 Guaribe, Gua´rico, Venezuela 1990 DF
95623 C6/36 1 Lara, Venezuela 1990 DF
96771 C6/36 1 Caracas, Dto. Federal, Venezuela 1990 DF
38998 C6/36 1 Niteroi, Rio de Janeiro, Brazil 1990 DF
39056 C6/36 1 Niteroi, Rio de Janeiro, Brazil 1990 DHF
40247 C6/36 2 Niteroi, Rio de Janeiro, Brazil 1990 DHF
41464 C6/36 2 Niteroi, Rio de Janeiro, Brazil 1990 DF
41576 C6/36 2 Niteroi, Rio de Janeiro, Brazil 1990 DF
previously described dengue 2 genotypes (Rico-Hesse, nucleotide site used for comparisons (map sites 2311–
2550) (Hahn et al., 1988).1990) was obtained in this manner.
Sequence analysis and phylogeniesPCR fragment sequencing
Nucleotide sequences for 18 of the strains shown hereBands of the correct size were cut from agarose gels
were reported previously (Accession Nos. M32932–and equilibrated in b-agarase buffer (10 mM Tris–HCl,
M32971) (Rico-Hesse, 1990). The remainder of dengue1 mM EDTA, pH 6.5) (NE Biolabs). Agarose was digested
type 2 sequences were submitted to GenBank. Sequenceswith 6 U of b-agarase enzyme (NE Biolabs) and the DNA
for the homologous region of serotype 1 virus (strain D81-fragments were precipitated and washed in ethanol, ac-
135, Thailand, 1981), serotype 3 virus (strain H87, Philip-cording to the manufacturer’s instructions. The DNA was
pines, 1956), and serotype 4 virus (strain 814669, Dominica,resuspended in DEPC water and 14 of this sample was
used in dideoxynucleotide sequencing reactions. Se- 1981) were obtained from GenBank (Accession Nos.
M32925, M93130, and M14931, respectively). Alignmentsquencing was done manually, using the Sequenase 2.0
Kit (U.S. Biochemical, Amersham), according to the man- were done using encoded amino acids; none of the viruses
compared here had additions or deletions in this regionufacturer’s instructions, including pyrophosphatase and
[a-35S]dATP. Two primer-extension reactions, using the of the genome. Phylogenetic analyses were done using
the PAUP program, with uniform character weights, TBRD2/2578 primer and D2/2452 (5*-CCACATTTCAGTTC-
TTT-3*), provided clear results and overlap at the 240- branch-swapping, and a heuristic search for the most par-
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TABLE 1—Continued
Strain Passage historya Locationb Year Clinicalc
102091 C6/36 1 Ta´chira, Venezuela 1991 DHF
102586 C6/36 1 Caracas, Dto. Federal, Venezuela 1991 DF
102692 None Aragua, Venezuela 1991 DHF
102781 C6/36 1 Apure, Venezuela 1991 DF
H506525 C6/36 2 Araguaina, Tocantins, Brazil 1991 DF
D91-157 Ts 1, C6/36 1 Bangkok, Thailand 1991 DHF
D92-287 Ts 1, C6/36 1 Bangkok, Thailand 1992 DF
360236 None Bucaramanga, Santander, Colombia 1992 DF
360281 None Ibague´, Tolima, Colombia 1992 DF
131 C6/36 1 Navojoa, Sonora, Mexico 1992 DF
132 C6/36 1 Navojoa, Sonora, Mexico 1992 DF
147 C6/36 1 ChıB nipas, Chihuahua, Mexico 1992 DF
125270 C6/36 1 Ta´chira, Venezuela 1993 DF
KD93-439 Ts 1, C6/36 1 Bangkok, Thailand 1993 DHF
E725 None Aragua, Venezuela 1994 DF
1380 None Portuguesa, Venezuela 1994 DF
1452 None Miranda, Venezuela 1994 DHF
2722 None Aragua, Venezuela 1995 DF
3602 None BolıB var, Venezuela 1995 DF
4203 None Ta´chira, Venezuela 1995 DF
8697 None Me´rida, Venezuela 1995 DHF
210097 None Cali, Valle del Cauca, Colombia 1995 DF
195 None Suchiapa, Chiapas, Mexico 1995 DF
203 None Comalapa, Chiapas, Mexico 1995 DF
204 None Tapachula, Chiapas, Mexico 1995 DF
382 None Tapachula, Chiapas, Mexico 1995 DHF
383 None Tamazunchale, S. L. Potosı´, Mexico 1995 DHF
a monk., rhesus monkey; mosq., whole mosquito; C6/36, Aedes albopictus cell line; smb., suckling mouse brain; MK2, LLC-MK2 monkey kidney
cell line; PGMK, primary green monkey kidney cell line; Ts, Toxorynchites splendens mosquito; none, acute serum of patient; AP61, Aedes pseudoscu-
tellaris cell line.
b City and/or state, country.
c DF, dengue fever; DHF, dengue hemorrhagic fever; Ae. africanus mosquito.
simonious trees (Swofford, 1993); sequences from repre- cause of the small sample size from that country and
time period. Thus, a total of 55 dengue type 2 virusessentatives of the other three serotypes (1, 3, and 4) were
were included in the resulting phylogenetic tree.used to root the trees. The reliability of the inferred trees
Comparison of these 240-nucleotide-long fragmentswas estimated using the bootstrap method, with 100 repli-
using maximum parsimony analysis generated phyloge-cations (Felsenstein, 1985).
netic or evolutionary trees (Fig. 1) that closely resemble
those published previously (Rico-Hesse, 1990). The fiveRESULTS
genotypic groups described before are represented in
Nucleotide sequences from the E/NS1 gene junction Fig. 1: one isolate from Guinea, 1981 (African sylvatic
were identical for several viruses from the same country cycle); one from Sri Lanka, 1985 (originally containing
and general time period. All isolates from the 1990 Brazil samples from Indonesia, the Seychelles, Burkina Faso,
epidemic (38998, 39056, 40247, 41464, and 41576) were and Sri Lanka); a group from the Caribbean, Mexico, and
identical, as were isolates from Tolima, Colombia, in South America (originally containing samples from the
1987 and 1988 (350447, 351863); some isolates from Ven- South Pacific also); a group containing isolates from Ja-
ezuela in 1990 (95524, 96771), from Colombia in 1992 maica, Vietnam, Thailand, and others from the Americas;
(360236, 360281), and from Mexico in 1995 (195, 382), and a group containing the New Guinea prototype virus
although from different locations in those countries, were along with Thai and American samples (originally con-
also identical. This may reflect the wide transmission taining isolates from Taiwan and the Philippines also).
(stability in time) of a given genotype of dengue virus or Bootstrap values among the five genotype groups ranged
its transport to a more distant geographic area (in the from 100 to 57%, thus supporting the tree branching pat-
latter cases). Most identical sequences were excluded tern shown in Fig. 1. The position of strain TR1751 (Trini-
from subsequent phylogenetic analyses; only those from dad 1954) relative to the American genotype group and
some of the strains within the two Southeast Asia geno-Tolima, Colombia (1987 and 1988) were included, be-
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FIG. 1. Phylogenetic tree generated by PAUP analysis of nucleotide sequences from the E/NS1 junction of 55 dengue type 2 viruses and
representatives of types 1, 3, and 4. Viruses are listed by strain number followed by abbreviation for country and year (see Table 1). Bootstrap
values are in boldface below the branches that connect each of the five genotypic groups of dengue type 2 and the outgroup (three type
representatives). Branch length is proportional to bar representing 10 nucleotide substitutions.
typic groups differed among the most parsimonious genetic trees. The genetic relationships were similar
whether the compared nucleotide sequences were fromtrees. These evolutionary relationships among dengue
type 2 viruses have been shown to be similar when other an entire gene (e.g., E or NS1) (Blok et al., 1989, 1991;
Lewis et al., 1993) or portions of genes (e.g., 198 nucleo-regions of the viral genome were used to generate phylo-
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tides of the E gene) (Deubel et al., 1993), and they were
independent of the type of phylogenetic analysis algo-
rithms used (e.g., UPMGA, NJ, or PAUP) (Blok et al., 1989,
1991; Deubel et al., 1993; Lewis et al., 1993).
As can be seen at the top of Fig. 1, viruses obtained
from the Caribbean and from South America previous to
1990 fell into the same group, including three samples
from northwestern Mexico obtained in 1992. Dengue ser-
otype 2 virus was first isolated in Brazil in 1990 so previ-
ous samples were not available for study (Pan American
Health Organization, 1992). These samples from Puerto
Rico, Colombia, Venezuela, and Mexico, from different
years, represent the ‘‘native’’ American genotype; this
group of viruses apparently had been evolving indepen-
dently for some time and their closest relative (and possi-
bly their progenitor) is the 1954 isolate from Trinidad.
Virus samples obtained from South America during
FIG. 2. Map of dengue type 2 samples from the Americas, according
and after 1990 and from Mexico in 1995 fell into either to case location and clinical classification.
of two other genotype groups containing isolates from
Southeast Asia or Jamaica. The latter group contains
three isolates from Jamaica which were postulated to mission characteristics described for Thailand in the past
(Trent et al., 1989; Walker et al., 1988). The inclusion ofhave been introduced to the Caribbean during the 1981
Cuban epidemic (Rico-Hesse, 1990). The inclusion of more recent isolates from Thailand (through 1993) sup-
ports the conclusion that many genetic variants havethree isolates from Thailand (D80-141, D81-081, and D8-
137) from the 1980–1982 period further support the view circulated in this country. More detailed studies of den-
gue transmission in these countries might help elucidatethat virus from Southeast Asia was probably introduced
to Cuba during the first major epidemic of DHF in the the population dynamics of this virus in conditions of
hyperendemicity.Americas. Samples from more recent (post-1989) dengue
virus outbreaks in Brazil, Colombia, Venezuela, and Mex- In terms of clinical presentation of disease (DF vs
DHF), there was no segregation of samples in the phylo-ico, including those from patients with DHF, fell into the
genotypic groups containing the most ancestral South- genetic tree; this is probably due to the use of nucleotide
sequences from the E/NS1 gene junction for constructingeast Asian viruses (see New Guinea 1944, Thailand 1964,
and Thailand 1980s). Venezuelan viruses, from a wide phylogenies. Other regions, such as those encoding anti-
genic domains (e.g., beginning and middle of E gene)range of locations and a long time period (1990–1995),
were distributed among these two ‘‘Southeast Asian’’ ge- (Megret et al., 1992), might contain sites important in
determining pathogenicity. Others have shown that anotypic groups, while samples from Brazil (1990 and
1991), Colombia (1992 and 1995), and Mexico (1995) Puerto Rican 1969 isolate (PR159) and a Brazilian 1990
isolate (40247), both included here, differ by 14/495 (2.8%)were limited to either of the two groups. Because caution
should be taken when interpreting the final branching amino acids in their E gene (Lewis et al., 1993). However,
biological markers of pathogenicity are required to iden-patterns (right side of the tree) of these genotypic groups,
it is impossible, using these data, to determine the direc- tify probable virulence determinants, and only full ge-
nome sequencing (of closely related strains) would prob-tion of spread or transmission of these viruses within or
among these American countries. However, it is clear ably yield information on location of possible determi-
nants. This study addressed only long-term evolutionaryfrom these data that the post-1989 samples from Brazil,
Colombia, Mexico, and Venezuela have a common pro- trends which could pinpoint the origin of more patho-
genic dengue strains.genitor with isolates or samples from Southeast Asia;
this suggests that the direction of transmission was from Figure 2 shows the geographic range of sampling in
the Americas, with the clinical classification of casesSoutheast Asia to the Americas.
Epidemiologically, Venezuela has recently been con- according to WHO criteria (World Health Organization,
1986). All DHF cases included here occurred during thesidered a region of dengue virus hyperendemicity be-
cause of the very large number of cases of DF and DHF period 1990–1995; only samples from a total of eight
cases were obtained because of the low rates of confir-reported yearly since 1990 (Gubler and Clark, 1995;
World Health Organization, 1996). This is reflected in the mation of disease etiology (i.e., virus isolation). Of the
four American countries chosen for comparison, only Co-large number of genetic variants of dengue type 2 from
this country (Fig. 1); this variability resembles the trans- lombia lacked a DHF sample. Because samples from DF
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and DHF cases from the other countries included here strain of dengue type 2 (Gubler and Clark, 1995), would
probably be efficient at interrupting the transmission ofare not distinguishable by comparison of these 240-nu-
cleotide-long fragments, we have assumed that Colom- the ‘‘virulent’’ type of virus. The genetic monitoring of virus
transmission, using an approach such as that describedbian DF samples are representative of those that might
have been obtained from DHF cases. Further analysis of here, would be very useful in future control efforts.
case samples from Colombia should clarify this obser-
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